Hyperprolactinemia and impotence.
One hundred impotent men and 15 sexually active male volunteers served as the source for this study. Serum prolactin was estimated in all cases using radioimmunoassay technique. Cases with hyperprolactinemia were treated with bromocriptine for 3 months. Hyperprolactinemia was detected in three patients only (3%), with no findings of pituitary tumors. Treatment with bromocriptine markedly reduced the level of serum prolactin together with improvement of sexual libido and potency. The mere presence of 3 cases only with hyperprolactinemia among 100 impotent subjects suggested that hyperprolactinemia is not one of the main causes of impotence.
el-Beheiry
A
A
Department of Dermatology, Faculty of Medicine, Alexandria University, Egypt.
Souka
A
A
el-Kamshoushi
A
A
Hussein
S
S
el-Sabah
K
K
D000293:Adolescent; D000328:Adult; D001971:Bromocriptine / Q000627:therapeutic use; D007172:Erectile Dysfunction / Q000188:drug therapy / Q000209:etiology*; D006801:Humans; D006966:Hyperprolactinemia / Q000150:complications* / Q000175:diagnosis / Q000188:drug therapy; D008297:Male; D008875:Middle Aged; D011388:Prolactin / Q000097:blood
D001971:Bromocriptine; D011388:Prolactin